10% owner ARCH Venture Fund X, L.P. adds $20M of Aspen Neuroscience, Inc. stock
The 10% owner paid an average of $15.00 a share, according to a Form 4 filed with the SEC on Nov 2.
A Form 4 filed on Nov 2 shows ARCH Venture Fund X, L.P., a holder of more than 10% of Aspen Neuroscience, Inc., buying 1,333,333 shares worth about $20 million on Nov 2, at about $15.00 each.
The shares were bought in 2 transactions, at prices that average $15.00. The trade was reported within two business days, as Section 16 requires.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Aspen Neuroscience, Inc. (ASPE) |
|---|---|
| Insider | ARCH Venture Fund X, L.P. |
| Role | 10% owner |
| Transaction | Open-market purchase (code P) |
| Shares | 1,333,333 |
| Average price | $15.00 |
| Value | $19,999,995 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 2, 2026, 9:50 PM ET |
| Ownership | Direct and indirect |
| Rule 10b5-1 plan | Not marked in the filing |
| Date | Shares | Price | Value | Ownership |
|---|---|---|---|---|
| Nov 2 | 133,333 | $15.00 | $1,999,995 | Direct |
| Nov 2 | 1,200,000 | $15.00 | $18,000,000 | Indirect |
See every transaction in this Aspen Neuroscience, Inc. filing
See more large insider purchases · Read more ASPE insider trading news
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
